هایپرآلژزی (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "هایپرآلژزی" in Persian language version.

refsWebsite

Global rank Persian rank

32nih.gov

4^th place

5^th place

29doi.org

2^nd place

15semanticscholar.org

11^th place

52^nd place

11worldcat.org

5^th place

12^th place

4archive.org

6^th place

9^th place

1wiley.com

222^nd place

185^th place

1thelancet.com

2,393^rd place

5,046^th place

1web.archive.org

1^st place

1clinicalpharmacology-ip.com

low place

1medicalnewstoday.com

3,011^th place

459^th place

1harvard.edu

18^th place

50^th place

archive.org

Hart BL (1988). "Biological basis of the behavior of sick animals". Neurosci Biobehav Rev. 12 (2): 123–37. doi:10.1016/S0149-7634(88)80004-6. PMID 3050629. S2CID 17797005.
Maier SF, Wiertelak EP, Martin D, Watkins LR (October 1993). "Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin". Brain Res. 623 (2): 321–24. doi:10.1016/0006-8993(93)91446-Y. PMID 8221116. S2CID 40529634.
Gottrup H, Juhl G, Kristensen AD, et al. (December 2004). "Chronic oral Gabapentin reduces elements of central sensitization in human experimental Hyperalgesia". Anesthesiology. 101 (6): 1400–08. doi:10.1097/00000542-200412000-00021. PMID 15564948. S2CID 15060257.
Chizh BA, Göhring M, Tröster A, Quartey GK, Schmelz M, Koppert W (February 2007). "Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers". Br J Anaesth. 98 (2): 246–54. doi:10.1093/bja/ael344. PMID 17251214.

clinicalpharmacology-ip.com

«Clinical Pharmacology». www.clinicalpharmacology-ip.com. بایگانی‌شده از اصلی در ۱۸ نوامبر ۲۰۲۱. دریافت‌شده در ۲۰۲۱-۱۱-۱۸.

doi.org

Woolf, Clifford J. (March 2002). "Central sensitization: implications for the diagnosis and treatment of pain". Pain. 152 (3 Suppl): S2–S15. doi:10.1016/j.pain.2010.09.030. ISSN 1872-6623. PMC 3268359. PMID 20961685.
Dickenson, Anthony H.; Matthews, Elizabeth A.; Suzuki, Rie (2002). "Neurobiology of neuropathic pain: mode of action of anticonvulsants". European Journal of Pain (به انگلیسی). 6 (SA): 51–60. doi:10.1053/eujp.2001.0323. ISSN 1532-2149.
Jensen, Troels S.; Finnerup, Nanna B. (2014-09-01). "Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms". The Lancet Neurology (به انگلیسی). 13 (9): 924–935. doi:10.1016/S1474-4422(14)70102-4. ISSN 1474-4422. PMID 25142459.
Hart BL (1988). "Biological basis of the behavior of sick animals". Neurosci Biobehav Rev. 12 (2): 123–37. doi:10.1016/S0149-7634(88)80004-6. PMID 3050629. S2CID 17797005.
Chu, Larry F.; Angst, Martin S.; Clark, David (June 2008). "Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations". The Clinical Journal of Pain. 24 (6): 479–496. doi:10.1097/AJP.0b013e31816b2f43. ISSN 1536-5409. PMID 18574358.
Marchand, Fabien; Perretti, Mauro; McMahon, Stephen B. (June 2005). "Role of the immune system in chronic pain". Nature Reviews. Neuroscience. 6 (7): 521–532. doi:10.1038/nrn1700. ISSN 1471-003X. PMID 15995723.
DuPen, Anna; Shen, Danny; Ersek, Mary (August 2007). "Mechanisms of opioid-induced tolerance and hyperalgesia". Pain Management Nursing: Official Journal of the American Society of Pain Management Nurses. 8 (3): 113–121. doi:10.1016/j.pmn.2007.02.004. ISSN 1524-9042. PMID 17723928.
Mitra, Sukanya (May 2008). "Opioid-induced hyperalgesia: pathophysiology and clinical implications". Journal of Opioid Management. 4 (3): 123–130. doi:10.5055/jom.2008.0017. ISSN 1551-7489. PMID 18717507.
Tamai H, Sawamura S, Takeda K, Orii R, Hanaoka K (March 2005). "Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation". Eur. J. Pharmacol. 510 (3): 223–28. doi:10.1016/j.ejphar.2005.01.033. PMID 15763246.
Ikeda H, Stark J, Fischer H, et al. (June 2006). "Synaptic amplifier of inflammatory pain in the spinal dorsal horn". Science. 312 (5780): 1659–62. Bibcode:2006Sci...312.1659I. doi:10.1126/science.1127233. PMID 16778058. S2CID 20540556.
Kelley KW, Bluthé RM, Dantzer R, et al. (February 2003). "Cytokine-induced sickness behavior". Brain Behav. 17 (Suppl 1): S112–18. doi:10.1016/S0889-1591(02)00077-6. PMID 12615196. S2CID 25400611.
Maier SF, Wiertelak EP, Martin D, Watkins LR (October 1993). "Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin". Brain Res. 623 (2): 321–24. doi:10.1016/0006-8993(93)91446-Y. PMID 8221116. S2CID 40529634.
de Plater GM, Milburn PJ, Martin RL (March 2001). "Venom from the platypus, Ornithorhynchus anatinus, induces a calcium-dependent current in cultured dorsal root ganglion cells". J. Neurophysiol. 85 (3): 1340–45. doi:10.1152/jn.2001.85.3.1340. PMID 11248005. S2CID 2452708.
Haanpää, Maija; Attal, Nadine; Backonja, Miroslav; Baron, Ralf; Bennett, Michael; Bouhassira, Didier; Cruccu, Giorgio; Hansson, Per; Haythornthwaite, Jennifer A. (January 2011). "NeuPSIG guidelines on neuropathic pain assessment". Pain. 152 (1): 14–27. doi:10.1016/j.pain.2010.07.031. ISSN 1872-6623. PMID 20851519.
Jensen, Troels S.; Finnerup, Nanna B. (August 2014). "Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms". The Lancet. Neurology. 13 (9): 924–935. doi:10.1016/S1474-4422(14)70102-4. ISSN 1474-4465. PMID 25142459.
Sindrup SH, Otto M, Finnerup NB, Jensen TS (June 2005). "Antidepressants in the treatment of neuropathic pain". Basic Clin. Pharmacol. Toxicol. 96 (6): 399–409. doi:10.1111/j.1742-7843.2005.pto_96696601.x. PMID 15910402.
Matsuzawa-Yanagida K, Narita M, Nakajima M, et al. (July 2008). "Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites". Neuropsychopharmacology. 33 (8): 1952–65. doi:10.1038/sj.npp.1301590. PMID 17957217.
Koppert W, Wehrfritz A, Körber N, et al. (March 2004). "The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans". Pain. 108 (1–2): 148–53. doi:10.1016/j.pain.2003.12.017. PMID 15109518. S2CID 33124447.
Koppert W, Wehrfritz A, Körber N, et al. (March 2004). "The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans". Pain. 108 (1–2): 148–53. doi:10.1016/j.pain.2003.12.017. PMID 15109518. S2CID 33124447.
Stubhaug A, Romundstad L, Kaasa T, Breivik H (October 2007). "Methylprednisolone and Ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds". Acta Anaesthesiol Scand. 51 (9): 1138–46. doi:10.1111/j.1399-6576.2007.01415.x. PMID 17714578. S2CID 20639496.
Gottrup H, Juhl G, Kristensen AD, et al. (December 2004). "Chronic oral Gabapentin reduces elements of central sensitization in human experimental Hyperalgesia". Anesthesiology. 101 (6): 1400–08. doi:10.1097/00000542-200412000-00021. PMID 15564948. S2CID 15060257.
Chizh BA, Göhring M, Tröster A, Quartey GK, Schmelz M, Koppert W (February 2007). "Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers". Br J Anaesth. 98 (2): 246–54. doi:10.1093/bja/ael344. PMID 17251214.
Warncke T, Stubhaug A, Jørum E (August 1997). "Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary Hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo". Pain. 72 (1–2): 99–106. doi:10.1016/S0304-3959(97)00006-7. PMID 9272793. S2CID 1343794.
Christoph T, Kögel B, Strassburger W, Schug SA (2007). "Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models". Drugs in R&D. 8 (1): 51–57. doi:10.2165/00126839-200708010-00005. PMID 17249849. S2CID 10268544.
Warncke, T.; Stubhaug, A.; Jørum, E. (July 1997). "Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo". Pain. 72 (1–2): 99–106. doi:10.1016/s0304-3959(97)00006-7. ISSN 0304-3959. PMID 9272793.
Vorobeychik Y, Chen L, Bush MC, Mao J (September 2008). "Improved opioid analgesic effect following opioid dose reduction". Pain Med. 9 (6): 724–27. doi:10.1111/j.1526-4637.2008.00501.x. PMID 18816332.
Klein T, Magerl W, Hanschmann A, Althaus M, Treede RD (January 2008). "Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic Hyperalgesia". Eur J Pain. 12 (1): 17–29. doi:10.1016/j.ejpain.2007.02.002. PMID 17449306. S2CID 2875679.
DeSantana, JM; Walsh, DM; Vance, C; Rakel, BA; Sluka, KA (December 2008). "Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain". Current Rheumatology Reports. 10 (6): 492–99. doi:10.1007/s11926-008-0080-z. PMC 2746624. PMID 19007541.
Sluka, KA; Chandran, P (November 2002). "Enhanced reduction in hyperalgesia by combined administration of clonidine and TENS". Pain. 100 (1–2): 183–90. doi:10.1016/s0304-3959(02)00294-4. PMID 12435471. S2CID 12117342.

harvard.edu

ui.adsabs.harvard.edu

Ikeda H, Stark J, Fischer H, et al. (June 2006). "Synaptic amplifier of inflammatory pain in the spinal dorsal horn". Science. 312 (5780): 1659–62. Bibcode:2006Sci...312.1659I. doi:10.1126/science.1127233. PMID 16778058. S2CID 20540556.

medicalnewstoday.com

"Hyperalgesia: Causes, types, and treatment". www.medicalnewstoday.com (به انگلیسی). 2017-08-06. Retrieved 2021-11-18.

nih.gov

pubmed.ncbi.nlm.nih.gov

Woolf, Clifford J. (March 2002). "Central sensitization: implications for the diagnosis and treatment of pain". Pain. 152 (3 Suppl): S2–S15. doi:10.1016/j.pain.2010.09.030. ISSN 1872-6623. PMC 3268359. PMID 20961685.
Jensen, Troels S.; Finnerup, Nanna B. (2014-09-01). "Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms". The Lancet Neurology (به انگلیسی). 13 (9): 924–935. doi:10.1016/S1474-4422(14)70102-4. ISSN 1474-4422. PMID 25142459.
Hart BL (1988). "Biological basis of the behavior of sick animals". Neurosci Biobehav Rev. 12 (2): 123–37. doi:10.1016/S0149-7634(88)80004-6. PMID 3050629. S2CID 17797005.
Chu, Larry F.; Angst, Martin S.; Clark, David (June 2008). "Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations". The Clinical Journal of Pain. 24 (6): 479–496. doi:10.1097/AJP.0b013e31816b2f43. ISSN 1536-5409. PMID 18574358.
Lee, Marion; Silverman, Sanford M.; Hansen, Hans; Patel, Vikram B.; Manchikanti, Laxmaiah (March 2011). "A comprehensive review of opioid-induced hyperalgesia". Pain Physician. 14 (2): 145–161. ISSN 2150-1149. PMID 21412369.
Marchand, Fabien; Perretti, Mauro; McMahon, Stephen B. (June 2005). "Role of the immune system in chronic pain". Nature Reviews. Neuroscience. 6 (7): 521–532. doi:10.1038/nrn1700. ISSN 1471-003X. PMID 15995723.
DuPen, Anna; Shen, Danny; Ersek, Mary (August 2007). "Mechanisms of opioid-induced tolerance and hyperalgesia". Pain Management Nursing: Official Journal of the American Society of Pain Management Nurses. 8 (3): 113–121. doi:10.1016/j.pmn.2007.02.004. ISSN 1524-9042. PMID 17723928.
Mitra, Sukanya (May 2008). "Opioid-induced hyperalgesia: pathophysiology and clinical implications". Journal of Opioid Management. 4 (3): 123–130. doi:10.5055/jom.2008.0017. ISSN 1551-7489. PMID 18717507.
Tamai H, Sawamura S, Takeda K, Orii R, Hanaoka K (March 2005). "Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation". Eur. J. Pharmacol. 510 (3): 223–28. doi:10.1016/j.ejphar.2005.01.033. PMID 15763246.
Ikeda H, Stark J, Fischer H, et al. (June 2006). "Synaptic amplifier of inflammatory pain in the spinal dorsal horn". Science. 312 (5780): 1659–62. Bibcode:2006Sci...312.1659I. doi:10.1126/science.1127233. PMID 16778058. S2CID 20540556.
Kelley KW, Bluthé RM, Dantzer R, et al. (February 2003). "Cytokine-induced sickness behavior". Brain Behav. 17 (Suppl 1): S112–18. doi:10.1016/S0889-1591(02)00077-6. PMID 12615196. S2CID 25400611.
Maier SF, Wiertelak EP, Martin D, Watkins LR (October 1993). "Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin". Brain Res. 623 (2): 321–24. doi:10.1016/0006-8993(93)91446-Y. PMID 8221116. S2CID 40529634.
de Plater GM, Milburn PJ, Martin RL (March 2001). "Venom from the platypus, Ornithorhynchus anatinus, induces a calcium-dependent current in cultured dorsal root ganglion cells". J. Neurophysiol. 85 (3): 1340–45. doi:10.1152/jn.2001.85.3.1340. PMID 11248005. S2CID 2452708.
Haanpää, Maija; Attal, Nadine; Backonja, Miroslav; Baron, Ralf; Bennett, Michael; Bouhassira, Didier; Cruccu, Giorgio; Hansson, Per; Haythornthwaite, Jennifer A. (January 2011). "NeuPSIG guidelines on neuropathic pain assessment". Pain. 152 (1): 14–27. doi:10.1016/j.pain.2010.07.031. ISSN 1872-6623. PMID 20851519.
Jensen, Troels S.; Finnerup, Nanna B. (August 2014). "Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms". The Lancet. Neurology. 13 (9): 924–935. doi:10.1016/S1474-4422(14)70102-4. ISSN 1474-4465. PMID 25142459.
Sindrup SH, Otto M, Finnerup NB, Jensen TS (June 2005). "Antidepressants in the treatment of neuropathic pain". Basic Clin. Pharmacol. Toxicol. 96 (6): 399–409. doi:10.1111/j.1742-7843.2005.pto_96696601.x. PMID 15910402.
Matsuzawa-Yanagida K, Narita M, Nakajima M, et al. (July 2008). "Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites". Neuropsychopharmacology. 33 (8): 1952–65. doi:10.1038/sj.npp.1301590. PMID 17957217.
Koppert W, Wehrfritz A, Körber N, et al. (March 2004). "The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans". Pain. 108 (1–2): 148–53. doi:10.1016/j.pain.2003.12.017. PMID 15109518. S2CID 33124447.
Koppert W, Wehrfritz A, Körber N, et al. (March 2004). "The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans". Pain. 108 (1–2): 148–53. doi:10.1016/j.pain.2003.12.017. PMID 15109518. S2CID 33124447.
Stubhaug A, Romundstad L, Kaasa T, Breivik H (October 2007). "Methylprednisolone and Ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds". Acta Anaesthesiol Scand. 51 (9): 1138–46. doi:10.1111/j.1399-6576.2007.01415.x. PMID 17714578. S2CID 20639496.
Gottrup H, Juhl G, Kristensen AD, et al. (December 2004). "Chronic oral Gabapentin reduces elements of central sensitization in human experimental Hyperalgesia". Anesthesiology. 101 (6): 1400–08. doi:10.1097/00000542-200412000-00021. PMID 15564948. S2CID 15060257.
Chizh BA, Göhring M, Tröster A, Quartey GK, Schmelz M, Koppert W (February 2007). "Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers". Br J Anaesth. 98 (2): 246–54. doi:10.1093/bja/ael344. PMID 17251214.
Warncke T, Stubhaug A, Jørum E (August 1997). "Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary Hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo". Pain. 72 (1–2): 99–106. doi:10.1016/S0304-3959(97)00006-7. PMID 9272793. S2CID 1343794.
Christoph T, Kögel B, Strassburger W, Schug SA (2007). "Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models". Drugs in R&D. 8 (1): 51–57. doi:10.2165/00126839-200708010-00005. PMID 17249849. S2CID 10268544.
Warncke, T.; Stubhaug, A.; Jørum, E. (July 1997). "Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo". Pain. 72 (1–2): 99–106. doi:10.1016/s0304-3959(97)00006-7. ISSN 0304-3959. PMID 9272793.
Vorobeychik Y, Chen L, Bush MC, Mao J (September 2008). "Improved opioid analgesic effect following opioid dose reduction". Pain Med. 9 (6): 724–27. doi:10.1111/j.1526-4637.2008.00501.x. PMID 18816332.
Klein T, Magerl W, Hanschmann A, Althaus M, Treede RD (January 2008). "Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic Hyperalgesia". Eur J Pain. 12 (1): 17–29. doi:10.1016/j.ejpain.2007.02.002. PMID 17449306. S2CID 2875679.
DeSantana, JM; Walsh, DM; Vance, C; Rakel, BA; Sluka, KA (December 2008). "Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain". Current Rheumatology Reports. 10 (6): 492–99. doi:10.1007/s11926-008-0080-z. PMC 2746624. PMID 19007541.
Sluka, KA; Chandran, P (November 2002). "Enhanced reduction in hyperalgesia by combined administration of clonidine and TENS". Pain. 100 (1–2): 183–90. doi:10.1016/s0304-3959(02)00294-4. PMID 12435471. S2CID 12117342.

ncbi.nlm.nih.gov

Woolf, Clifford J. (March 2002). "Central sensitization: implications for the diagnosis and treatment of pain". Pain. 152 (3 Suppl): S2–S15. doi:10.1016/j.pain.2010.09.030. ISSN 1872-6623. PMC 3268359. PMID 20961685.
Purves, Dale; Augustine, George J.; Fitzpatrick, David; Katz, Lawrence C.; LaMantia, Anthony-Samuel; McNamara, James O.; Williams, S. Mark (2001). "Hyperalgesia and Sensitization". Neuroscience. 2nd edition (به انگلیسی).
DeSantana, JM; Walsh, DM; Vance, C; Rakel, BA; Sluka, KA (December 2008). "Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain". Current Rheumatology Reports. 10 (6): 492–99. doi:10.1007/s11926-008-0080-z. PMC 2746624. PMID 19007541.

semanticscholar.org

api.semanticscholar.org

Hart BL (1988). "Biological basis of the behavior of sick animals". Neurosci Biobehav Rev. 12 (2): 123–37. doi:10.1016/S0149-7634(88)80004-6. PMID 3050629. S2CID 17797005.
Ikeda H, Stark J, Fischer H, et al. (June 2006). "Synaptic amplifier of inflammatory pain in the spinal dorsal horn". Science. 312 (5780): 1659–62. Bibcode:2006Sci...312.1659I. doi:10.1126/science.1127233. PMID 16778058. S2CID 20540556.
Kelley KW, Bluthé RM, Dantzer R, et al. (February 2003). "Cytokine-induced sickness behavior". Brain Behav. 17 (Suppl 1): S112–18. doi:10.1016/S0889-1591(02)00077-6. PMID 12615196. S2CID 25400611.
Maier SF, Wiertelak EP, Martin D, Watkins LR (October 1993). "Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin". Brain Res. 623 (2): 321–24. doi:10.1016/0006-8993(93)91446-Y. PMID 8221116. S2CID 40529634.
de Plater GM, Milburn PJ, Martin RL (March 2001). "Venom from the platypus, Ornithorhynchus anatinus, induces a calcium-dependent current in cultured dorsal root ganglion cells". J. Neurophysiol. 85 (3): 1340–45. doi:10.1152/jn.2001.85.3.1340. PMID 11248005. S2CID 2452708.
Koppert W, Wehrfritz A, Körber N, et al. (March 2004). "The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans". Pain. 108 (1–2): 148–53. doi:10.1016/j.pain.2003.12.017. PMID 15109518. S2CID 33124447.
Koppert W, Wehrfritz A, Körber N, et al. (March 2004). "The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans". Pain. 108 (1–2): 148–53. doi:10.1016/j.pain.2003.12.017. PMID 15109518. S2CID 33124447.
Stubhaug A, Romundstad L, Kaasa T, Breivik H (October 2007). "Methylprednisolone and Ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds". Acta Anaesthesiol Scand. 51 (9): 1138–46. doi:10.1111/j.1399-6576.2007.01415.x. PMID 17714578. S2CID 20639496.
Gottrup H, Juhl G, Kristensen AD, et al. (December 2004). "Chronic oral Gabapentin reduces elements of central sensitization in human experimental Hyperalgesia". Anesthesiology. 101 (6): 1400–08. doi:10.1097/00000542-200412000-00021. PMID 15564948. S2CID 15060257.
Warncke T, Stubhaug A, Jørum E (August 1997). "Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary Hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo". Pain. 72 (1–2): 99–106. doi:10.1016/S0304-3959(97)00006-7. PMID 9272793. S2CID 1343794.
Christoph T, Kögel B, Strassburger W, Schug SA (2007). "Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models". Drugs in R&D. 8 (1): 51–57. doi:10.2165/00126839-200708010-00005. PMID 17249849. S2CID 10268544.
Klein T, Magerl W, Hanschmann A, Althaus M, Treede RD (January 2008). "Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic Hyperalgesia". Eur J Pain. 12 (1): 17–29. doi:10.1016/j.ejpain.2007.02.002. PMID 17449306. S2CID 2875679.
Sluka, KA; Chandran, P (November 2002). "Enhanced reduction in hyperalgesia by combined administration of clonidine and TENS". Pain. 100 (1–2): 183–90. doi:10.1016/s0304-3959(02)00294-4. PMID 12435471. S2CID 12117342.

semanticscholar.org

Ikeda H, Stark J, Fischer H, et al. (June 2006). "Synaptic amplifier of inflammatory pain in the spinal dorsal horn". Science. 312 (5780): 1659–62. Bibcode:2006Sci...312.1659I. doi:10.1126/science.1127233. PMID 16778058. S2CID 20540556.
de Plater GM, Milburn PJ, Martin RL (March 2001). "Venom from the platypus, Ornithorhynchus anatinus, induces a calcium-dependent current in cultured dorsal root ganglion cells". J. Neurophysiol. 85 (3): 1340–45. doi:10.1152/jn.2001.85.3.1340. PMID 11248005. S2CID 2452708.

thelancet.com

Jensen, Troels S.; Finnerup, Nanna B. (2014-09-01). "Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms". The Lancet Neurology (به انگلیسی). 13 (9): 924–935. doi:10.1016/S1474-4422(14)70102-4. ISSN 1474-4422. PMID 25142459.

web.archive.org

«Clinical Pharmacology». www.clinicalpharmacology-ip.com. بایگانی‌شده از اصلی در ۱۸ نوامبر ۲۰۲۱. دریافت‌شده در ۲۰۲۱-۱۱-۱۸.

wiley.com

onlinelibrary.wiley.com

Dickenson, Anthony H.; Matthews, Elizabeth A.; Suzuki, Rie (2002). "Neurobiology of neuropathic pain: mode of action of anticonvulsants". European Journal of Pain (به انگلیسی). 6 (SA): 51–60. doi:10.1053/eujp.2001.0323. ISSN 1532-2149.

worldcat.org

Woolf, Clifford J. (March 2002). "Central sensitization: implications for the diagnosis and treatment of pain". Pain. 152 (3 Suppl): S2–S15. doi:10.1016/j.pain.2010.09.030. ISSN 1872-6623. PMC 3268359. PMID 20961685.
Dickenson, Anthony H.; Matthews, Elizabeth A.; Suzuki, Rie (2002). "Neurobiology of neuropathic pain: mode of action of anticonvulsants". European Journal of Pain (به انگلیسی). 6 (SA): 51–60. doi:10.1053/eujp.2001.0323. ISSN 1532-2149.
Jensen, Troels S.; Finnerup, Nanna B. (2014-09-01). "Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms". The Lancet Neurology (به انگلیسی). 13 (9): 924–935. doi:10.1016/S1474-4422(14)70102-4. ISSN 1474-4422. PMID 25142459.
Chu, Larry F.; Angst, Martin S.; Clark, David (June 2008). "Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations". The Clinical Journal of Pain. 24 (6): 479–496. doi:10.1097/AJP.0b013e31816b2f43. ISSN 1536-5409. PMID 18574358.
Lee, Marion; Silverman, Sanford M.; Hansen, Hans; Patel, Vikram B.; Manchikanti, Laxmaiah (March 2011). "A comprehensive review of opioid-induced hyperalgesia". Pain Physician. 14 (2): 145–161. ISSN 2150-1149. PMID 21412369.
Marchand, Fabien; Perretti, Mauro; McMahon, Stephen B. (June 2005). "Role of the immune system in chronic pain". Nature Reviews. Neuroscience. 6 (7): 521–532. doi:10.1038/nrn1700. ISSN 1471-003X. PMID 15995723.
DuPen, Anna; Shen, Danny; Ersek, Mary (August 2007). "Mechanisms of opioid-induced tolerance and hyperalgesia". Pain Management Nursing: Official Journal of the American Society of Pain Management Nurses. 8 (3): 113–121. doi:10.1016/j.pmn.2007.02.004. ISSN 1524-9042. PMID 17723928.
Mitra, Sukanya (May 2008). "Opioid-induced hyperalgesia: pathophysiology and clinical implications". Journal of Opioid Management. 4 (3): 123–130. doi:10.5055/jom.2008.0017. ISSN 1551-7489. PMID 18717507.
Haanpää, Maija; Attal, Nadine; Backonja, Miroslav; Baron, Ralf; Bennett, Michael; Bouhassira, Didier; Cruccu, Giorgio; Hansson, Per; Haythornthwaite, Jennifer A. (January 2011). "NeuPSIG guidelines on neuropathic pain assessment". Pain. 152 (1): 14–27. doi:10.1016/j.pain.2010.07.031. ISSN 1872-6623. PMID 20851519.
Jensen, Troels S.; Finnerup, Nanna B. (August 2014). "Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms". The Lancet. Neurology. 13 (9): 924–935. doi:10.1016/S1474-4422(14)70102-4. ISSN 1474-4465. PMID 25142459.
Warncke, T.; Stubhaug, A.; Jørum, E. (July 1997). "Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo". Pain. 72 (1–2): 99–106. doi:10.1016/s0304-3959(97)00006-7. ISSN 0304-3959. PMID 9272793.